BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in BioCardia, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +2 vs. Q1 2022
- Shares held
- 2.14M
- −513.7K (−19.4%) vs. Q1 2022
- Total value
- $3.10M
- −$2.38M (−43.4%) vs. Q1 2022
- New holders
- 4
- 5 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 78 | $0 | 0.00% | +8+11.4% | Added |
| Aspire Private Capital, LLC | 300 | $0 | 0.00% | +300 | New |
| Morgan Stanley | 983 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 900 | $1.00K | 0.00% | −100−10.0% | Reduced |
| Tower Research Capital LLC (TRC) | 758 | $1.00K | 0.00% | +758 | New |
| Simplex Trading, LLC | 2,260 | $3.00K | 0.00% | −595−20.8% | Reduced |
| UBS Group AG | 4,974 | $7.00K | 0.00% | +3,280+193.6% | Added |
| Bank of America Corp | 6,528 | $9.00K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 11,050 | $16.0K | 0.00% | 00.0% | Unchanged |
| Cetera Investment Advisers | 12,610 | $18.0K | 0.00% | +12,610 | New |
| Bank of New York Mellon Corp | 12,767 | $19.0K | 0.00% | −87−0.7% | Reduced |
| Renaissance Technologies LLC | 14,800 | $21.0K | 0.00% | +1,100+8.0% | Added |
| Citadel Advisors LLC | 17,675 | $26.0K | 0.00% | −26,020−59.5% | Reduced |
| Northern Trust Corp | 19,226 | $28.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,000 | $31.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 27,407 | $41.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 28,312 | $42.0K | 0.00% | +28,312 | New |
| Advisor Group Holdings, Inc. | 31,843 | $46.0K | 0.00% | −2,645−7.7% | Reduced |
| Brown Advisory Inc | 33,085 | $48.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 49,978 | $72.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 91,365 | $135.0K | 0.00% | +3,810+4.4% | Added |
| Susquehanna International Group, LLP | 108,842 | $161.0K | 0.00% | +36,514+50.5% | Added |
| CM Management, LLC | 329,000 | $477.0K | 0.51% | 00.0% | Unchanged |
| Vanguard Group Inc | 650,523 | $943.0K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 660,637 | $958.0K | 0.01% | 00.0% | Unchanged |
| IFP Advisors, Inc | 100 | – | – | 00.0% | Unchanged |
| Roumell Asset Management, LLC | 0 | $0 | 0.00% | −536,497−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −34,431−100.0% | Sold out |